Latest Regulatory Approvals News

Genesis Resources advances its exploration portfolio with 100% ownership of the Plavica project in North Macedonia and completes follow-up drilling in Australia, awaiting assay results.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for chronic wound treatment and advances regulatory filings for its TR Pro+® product, while gearing up for a major commercial rollout in early 2026.

Mount Hope Mining has raised $2.48 million through a placement and share purchase plan to accelerate drilling at its Mt Solitary gold prospect and the broader 7.5km gold corridor in the prolific Cobar Basin.

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

Rincon Resources has completed a significant drilling campaign at its Telfer South Gold Project, testing extensions well beyond its initial resource footprint, while early Laverton drilling results show modest gold grades. Assay results expected soon will be pivotal for the company’s next exploration phase.

CVC Limited is contemplating a fresh offer of Capital Notes, potentially including a reinvestment option for existing holders, contingent on market and regulatory conditions.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Strategic Energy Resources has advanced its copper-gold exploration in Queensland through government-backed drilling, a $3 million joint venture program, and a key acquisition from Anglo American, supported by a $2 million capital raise.

Cue Energy Resources reported steady production with notable gains at Mahato and Maari fields, alongside a new gas supply deal and a $3.5 million dividend payment.

CuFe Ltd has announced a dramatic 400% increase in contained copper at its Gecko project, alongside an upgraded Orlando resource and a $5.4 million capital raise to advance its Tennant Creek development plans.

Archer Materials has successfully demonstrated that its blood potassium Biochip can be fabricated on a silicon platform, matching clinical accuracy standards and accelerating its path to commercialisation.

Alligator Energy has commenced construction of its pivotal Samphire Field Recovery Trial, marking a significant shift from exploration to development. The company also bolstered its leadership team to support this growth phase and reported promising exploration results at its Big Lake Uranium Project.